PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32842332-15	2020	Conclusions: The IVMP therapy is effective for the NMO-ON relapse in patients who were AQP4 antibody seropositive.	4-methylmorpholine N-oxide	51-54	aquaporin 4	Homo sapiens	87-91	
20049472-7	2010	Three of 20 patients (two with NMO, one with recurrent myelitis) were seropositive for anti-AQP4 antibodies.	4-methylmorpholine N-oxide	31-34	aquaporin 4	Homo sapiens	92-96	
34782653-14	2021	Therefore, IVMP therapy can improve visual acuity in the affected eyes of patients with AQP4 antibody-seropositive NMO-ON with similar effect at 500 mg/day and 1000 mg/day doses.	4-methylmorpholine N-oxide	115-118	aquaporin 4	Homo sapiens	88-92